Newsletters

Summer 2006 Quarterly Newsletter

Research Funding at Record High - P.1
President’s Message - P.2
Zelapar Approved for Use in Parkinson's Disease - P.2
Clinical Trials and PD - P.3
Q & A - P.4
F.Y.I - P.5-7
APDA Research Funding for Fiscal Year 2006-2007 - P.8-9
Exelon Approved to Treat Parkinson's Disease - P.10
Stalevo's Evaluation in Early Parkinson's Disease - P.10
APDA Seed Money for Research - P.11
Air Travel Suggestions - P. 11
Information on Parkinson's Disease - P.12